Clinical Trial Update: An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 trial update of alirocumab in children and adolescents with heterozygous familial hypercholesterolemia; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hypercholesterolemia Familial

Drugs mentioned

• alirocumab (alirocumab)

Snippet

Sponsor: Sanofi | Conditions: Hypercholesterolaemia | Phase 3 | Status: COMPLETED | Results posted: 2023-05-06